Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid
Linda T. Vahdat(Dartmouth College), RP Jr Warrell(Memorial Sloan Kettering Cancer Center), Glenn Heller(Memorial Sloan Kettering Cancer Center), WH Jr Miller(Memorial Sloan Kettering Cancer Center), A Eardley(Memorial Sloan Kettering Cancer Center), P. Maslak(Memorial Sloan Kettering Cancer Center), DA Scheinberg(Memorial Sloan Kettering Cancer Center)
Cited by 303
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
|Nature|2015|1.8k
Connecting copper and cancer: from transition metal signalling to metalloplasia
|Nature reviews. Cancer|2021|1.3k
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
|The Lancet|2011|1.1k
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846